LONDON--(BUSINESS WIRE)--The rare genetic disease CDKL5 Deficiency Disorder (CDD) has been designated with a new disease code in the International Classification of Diseases (ICD), the medical classification list from the World Health Organization (WHO). The CDKL5 Deficiency Disorder diagnostic cod...
WHO于2022年发布WHO FPPL,高优先级和中优先级两个分组中所包含的部分罕见真菌发病率日渐升高,防治需要“对症下药”。 上期我们围绕世界卫生组织(WHO)于2022年发布的真菌病原体清单(WHO FPPL)“关键优先级”分组中的四个真菌,展开了详尽的讨论,基于发病率、死亡率、治疗方案和循证证据给出了相关数据及指南...
参考文献: [1]WHO fungal priority pathogens list to guide research, development, and public health action [2]Fernández-Cruz A, Semiglia MA, Guinea J, et al. A retrospective cohort of invasive fusariosis in the era of...
Despite his success, Kaufman's life was cut tragically short by a rare form of lung cancer in 1984. Yet, even his death was shrouded in uncertainty due to his history of elaborate pranks and hoaxes, leading some fans to believe it was another one of his surreal performance pieces. ...
and Zika were designated as "serious" problems requiring action by WHO to promote R&D as soon as possible. HIV/AIDS, tuberculosis, malaria, avian influenza, and dengue were not included in the list because these infections are already being addressed via major disease control and research networks...
Regulatory news Burosumab for a rare bone disease WHO Drug Information,2018,32,1 查看 Regulatory news Apalutamide for prostate cancer WHO Drug Information,2018,32,1 查看 Regulatory news Baloxavir marboxil one-dose treatment for influenza WHO Drug Information,2018,32,1 查看 Regulatory news ...
Regulatory news Burosumab for a rare bone disease WHO Drug Information,2018,32,1 查看 Regulatory news Apalutamide for prostate cancer WHO Drug Information,2018,32,1 查看 Regulatory news Baloxavir marboxil one-dose treatment for influenza WHO Drug Information,2018,32,1 查看 Regulatory news ...
- « Who rules rare disease associations ? A framework to understand their action », Sociology of health and illness, 31, 7, pp. 979-993.Huyard C., 2009, Who rules rare disease associations? A framework to understand their action, Sociology of Health & Illness, 31, 7, 979-993....
When at last they decided to merge in 1989, they created Novo Nordisk, a company that has been expanding rapidly ever since with leading positions within diabetes care, obesity care, haemophilia care, and therapies for rare endocrine disorders. ...
In addition to the data on reported ACM and the estimates from the GHE, the final dimension to the input data are variables that can potentially be used as predictors for excess mortality in those countries/time periods without ACM data. The strategy applied to create a covariate list was pra...